Literature DB >> 16770552

Effect of bisphosphonates on the stimulation of macrophages by alumina ceramic particles: a comparison with ultra-high-molecular-weight polyethylene.

Alain Petit1, Fackson Mwale, John Antoniou, David J Zukor, Olga L Huk.   

Abstract

Wear particle-induced osteolysis and loosening is a critical process that limits the longevity of total hip arthroplasty. Despite their potential value in the management of aseptic loosening, little is known about the cellular response to bisphosphonates (BPs) in the presence of particulate debris. In the present study, we compared the effect of pamidronate and clodronate, two structurally different bisphosphonates, on the induction of TNF-alpha release by alumina ceramic (Al(2)O(3)) and ultra-high-molecular-weight-polyethylene (UHMWPE) particles. We also looked, by Trypan blue exclusion, at the viability of J774 mouse macrophages incubated with Al(2)O(3) and UHMWPE particles in combination with pamidronate or clodronate. Results showed that pamidronate and clodronate can inhibit UHMWPE particle-induced TNF-alpha release while they had no effect on Al(2)O(3)-stimulated TNF-alpha release. The co-incubation of pamidronate or clodronate and Al(2)O(3) had no effect on the induction by Al(2)O(3) of poly(ADP-ribose)polymerase (PARP) proteolysis and DNA fragmentation. On the other hand, UHMWPE particles had no effect on these apoptotic markers. However, the co-incubation of pamidronate or clodronate with UHMWPE particles led to the appearance of these markers of apoptosis. Al(2)O(3) and UHMWPE particles had no effect on macrophage cell death or the number of macrophages at the end of experiments. Co-incubation of UHMWPE particles with pamidronate and clodronate led to a significant increase in cell death. Interestingly, the number of macrophages co-incubated with particles and pamidronate or clodronate significantly decreased. In conclusion, our results suggest that the effect of BPs on particle-stimulated macrophages is, at least in part, particle composition dependent.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770552     DOI: 10.1007/s10856-006-9230-x

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   4.727


  34 in total

1.  Effect of pamidronate in preventing local bone loss after total hip arthroplasty: a randomized, double-blind, controlled trial.

Authors:  J M Wilkinson; I Stockley; N F Peel; A J Hamer; R A Elson; N A Barrington; R Eastell
Journal:  J Bone Miner Res       Date:  2001-03       Impact factor: 6.741

Review 2.  Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases.

Authors:  C J Rosen; C R Kessenich
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 3.  The response to particulate debris.

Authors:  D W Howie; D R Haynes; S D Rogers; M A McGee; M J Pearcy
Journal:  Orthop Clin North Am       Date:  1993-10       Impact factor: 2.472

4.  Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty: a prospective randomized study.

Authors:  P K Venesmaa; H P Kröger; H J Miettinen; J S Jurvelin; O T Suomalainen; E M Alhav
Journal:  J Bone Miner Res       Date:  2001-11       Impact factor: 6.741

Review 5.  The pharmacology of bisphosphonates and new insights into their mechanisms of action.

Authors:  R G Russell; M J Rogers; J C Frith; S P Luckman; F P Coxon; H L Benford; P I Croucher; C Shipman; H A Fleisch
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

6.  Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages.

Authors:  S P Luckman; F P Coxon; F H Ebetino; R G Russell; M J Rogers
Journal:  J Bone Miner Res       Date:  1998-11       Impact factor: 6.741

7.  Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo.

Authors:  D E Hughes; K R Wright; H L Uy; A Sasaki; T Yoneda; G D Roodman; G R Mundy; B F Boyce
Journal:  J Bone Miner Res       Date:  1995-10       Impact factor: 6.741

8.  [Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study].

Authors:  A Nehme; G Maalouf; J-L Tricoire; G Giordano; P Chiron; J Puget
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  2003-11

9.  Effect of pamidronate on the stimulation of macrophage TNF-alpha release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis.

Authors:  Olga L Huk; David J Zukor; John Antoniou; Alain Petit
Journal:  J Orthop Res       Date:  2003-01       Impact factor: 3.494

Review 10.  Ceramics for total hip replacement--what a surgeon should know.

Authors:  G Willmann
Journal:  Orthopedics       Date:  1998-02       Impact factor: 1.390

View more
  3 in total

1.  A study on the prevention and treatment of murine calvarial inflammatory osteolysis induced by ultra-high-molecular-weight polyethylene particles with neomangiferin.

Authors:  Hong-Tao Wang; Jia Li; Shi-Ting Ma; Wen-Yu Feng; Qi Wang; Hong-Yan Zhou; Jin-Min Zhao; Jun Yao
Journal:  Exp Ther Med       Date:  2018-09-11       Impact factor: 2.447

2.  The Role of IL-6RA in UHMWPE Promotes Proliferation in Fibro-Like Synovial Cells.

Authors:  Xianlun Pang; Jiang Yang; Xiaoli Zhen; Hai Nie; Hao Qin; Lingyuan Huang; Lijie Zhang
Journal:  Biomed Res Int       Date:  2018-10-22       Impact factor: 3.411

3.  Significance of nano- and microtopography for cell-surface interactions in orthopaedic implants.

Authors:  M Jäger; C Zilkens; K Zanger; R Krauspe
Journal:  J Biomed Biotechnol       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.